Cargando…
Neutralizing Antibody Response to BBIBP-CorV in Comparison with COVID-19 Recovered, Unvaccinated Individuals in a Sample of the Pakistani Population
Fifty five percent of the Pakistani population is still unvaccinated with the two-dose protocol of COVID-19 vaccines. This study was undertaken to determine the seroconversion rate and antibody titers following the two-dose BBIBP-CorV protocol, and to compare these variables in unvaccinated, COVID-1...
Autores principales: | Aijaz, Javeria, Hussain, Shakir, Naseer, Fouzia, Kanani, Fatima, Anis, Sabiha, Sarfaraz, Samreen, Saeed, Saima, Farooq, Hina, Jamal, Saba |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171576/ https://www.ncbi.nlm.nih.gov/pubmed/35632448 http://dx.doi.org/10.3390/vaccines10050692 |
Ejemplares similares
-
BBIBP-CorV: Hepatitis: case report
Publicado: (2022) -
BBIBP-CorV: Anterior uveitis: case report
Publicado: (2022) -
Persistence of immune responses to the Sinopharm/BBIBP‐CorV vaccine
por: Jeewandara, Chandima, et al.
Publicado: (2022) -
BBIBP-CorV: Steven-Johnson syndrome : case report
Publicado: (2022) -
BBIBP-CorV: Acute disseminated encephalomyelitis: case report
Publicado: (2022)